Pharmacopsychiatry
Issue 01 · January 2022
Recommend Journal
eFirst
Issue
Editorial
5
Bauer, Michael; Juckel, Georg:
Covid-19: Contributions from Psychopharmacology
Full Text
HTML
PDF (111 kb)
Review
7
Mueller, Juliane K.; Riederer, Peter; Müller, Walter E.:
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?
FREE ACCESS
Full Text
HTML
PDF (310 kb)
16
Khosravi, Mohsen:
Candidate Psychotropics against SARS – CoV – 2: A Narrative Review
Full Text
HTML
PDF (208 kb)
24
Nykamp, Madeline J.; Zorumski, Charles F.; Reiersen, Angela M.; Nicol, Ginger E.; Cirrito, John; Lenze, Eric J.:
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease Prevention
Full Text
HTML
PDF (352 kb)
Supplementary Material
Supplementary Material
48
Veerman, Selene R. T.; Bogers, Jan P. A. M.; Cohen, Dan; Schulte, Peter F. J.:
COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine
Full Text
HTML
PDF (499 kb)
Original Paper
30
Bonnet, Udo; Claus, BenediktBernd; Schaefer, Martin; Kuhn, Jens; Nyhuis, Peter; Scherbaum, Norbert; Brüne, Martin; Wakili, Velat; Juckel, Georg:
Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German Metropolitan Ruhr-area
Full Text
HTML
PDF (452 kb)
40
Plasencia-García, Beatriz Oda; Rico-Rangel, María Isabel; Rodríguez-Menéndez, Gonzalo; Rubio-García, Ana; Torelló-Iserte, Jaime; Crespo-Facorro, Benedicto:
Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases
Full Text
HTML
PDF (2665 kb)
Supplementary Material
Supplementary Material
Letter to the Editor
57
Papadopoulos, Konstantinos I.; Sutheesophon, Warachaya; Aw, Tar-Choon:
Anti-SARS-CoV-2 Action of Fluvoxamine may be Mediated by Endothelial Nitric Oxide Synthase
Full Text
HTML
PDF (114 kb)
58
Khosravi, Mohsen:
A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection
Full Text
HTML
PDF (98 kb)
Most Read
Archive
Free Sample Issue
Journal
About
Editorial Board
German National License
Imprint
Bluesky
Linkedin
Authors
Information for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licencing
AGNP
Information for Authors
Submit a Manuscript
Collections
Information for Authors
Submit a Manuscript
Journals
Book Series
Login
Help
Portal
Return to Classic Website
